305 related articles for article (PubMed ID: 15916700)
1. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.
Arnsten AF; Dudley AG
Behav Brain Funct; 2005 Apr; 1(1):2. PubMed ID: 15916700
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.
Gamo NJ; Wang M; Arnsten AF
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1011-23. PubMed ID: 20855046
[TBL] [Abstract][Full Text] [Related]
3. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors.
Gronier B
Eur Neuropsychopharmacol; 2011 Feb; 21(2):192-204. PubMed ID: 21146374
[TBL] [Abstract][Full Text] [Related]
4. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
[TBL] [Abstract][Full Text] [Related]
5. Stimulants: Therapeutic actions in ADHD.
Arnsten AF
Neuropsychopharmacology; 2006 Nov; 31(11):2376-83. PubMed ID: 16855530
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
Berridge CW; Devilbiss DM; Andrzejewski ME; Arnsten AF; Kelley AE; Schmeichel B; Hamilton C; Spencer RC
Biol Psychiatry; 2006 Nov; 60(10):1111-20. PubMed ID: 16806100
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors.
Berridge CW; Shumsky JS; Andrzejewski ME; McGaughy JA; Spencer RC; Devilbiss DM; Waterhouse BD
Biol Psychiatry; 2012 Mar; 71(5):467-73. PubMed ID: 21890109
[TBL] [Abstract][Full Text] [Related]
8. Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants.
Spencer RC; Berridge CW
Neuropsychopharmacology; 2019 Sep; 44(10):1820-1827. PubMed ID: 30683912
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors.
Rozas C; Carvallo C; Contreras D; Carreño M; Ugarte G; Delgado R; Zeise ML; Morales B
Neuropharmacology; 2015 Dec; 99():15-27. PubMed ID: 26165920
[TBL] [Abstract][Full Text] [Related]
11. Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge.
Devilbiss DM; Berridge CW
J Pharmacol Exp Ther; 2006 Dec; 319(3):1327-35. PubMed ID: 16980569
[TBL] [Abstract][Full Text] [Related]
12. Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Yorbik O; Mutlu C; Ozilhan S; Eryilmaz G; Isiten N; Alparslan S; Saglam E
Ther Drug Monit; 2015 Jun; 37(3):347-52. PubMed ID: 25384118
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.
Engert V; Pruessner JC
Curr Neuropharmacol; 2008 Dec; 6(4):322-8. PubMed ID: 19587853
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.
Zhang CL; Feng ZJ; Liu Y; Ji XH; Peng JY; Zhang XH; Zhen XC; Li BM
PLoS One; 2012; 7(12):e51910. PubMed ID: 23284812
[TBL] [Abstract][Full Text] [Related]
15. Aberrant CaMKII activity in the medial prefrontal cortex is associated with cognitive dysfunction in ADHD model rats.
Yabuki Y; Shioda N; Maeda T; Hiraide S; Togashi H; Fukunaga K
Brain Res; 2014 Apr; 1557():90-100. PubMed ID: 24561222
[TBL] [Abstract][Full Text] [Related]
16. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
[TBL] [Abstract][Full Text] [Related]
17. Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors.
Andrews GD; Lavin A
Neuropsychopharmacology; 2006 Mar; 31(3):594-601. PubMed ID: 15999146
[TBL] [Abstract][Full Text] [Related]
18. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS.
Monden Y; Dan H; Nagashima M; Dan I; Kyutoku Y; Okamoto M; Yamagata T; Momoi MY; Watanabe E
Clin Neurophysiol; 2012 Jun; 123(6):1147-57. PubMed ID: 22088661
[TBL] [Abstract][Full Text] [Related]
19. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
Ince Tasdelen B; Karakaya E; Oztop DB
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
[TBL] [Abstract][Full Text] [Related]
20. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
Rhodes SM; Coghill DR; Matthews K
J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]